or Try an Advanced Search...

    Hematologic Malignancies Stocks List

    Symbol Grade Name % Change
    AFMD D Affimed Therapeutics B.V. -3.49
    APTO F Aptose Biosciences, Inc. -0.84
    CRBU F Caribou Biosciences, Inc. -5.57
    CLLS B Cellectis S.A. -1.64
    FATE F Fate Therapeutics, Inc. -5.80
    INMB C INmune Bio Inc. -2.86
    INCY D Incyte Corporation 0.42
    KYMR C Kymera Therapeutics, Inc. -1.83
    PRTC B PureTech Health plc 0.00
    SLS C SELLAS Life Sciences Group, Inc. -0.68
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Solid Tumors Cancer Medicine Biotechnology Clinical Medicine Acute Myeloid Leukemia CD19 Tumors Of The Hematopoietic And Lymphoid Tissues Biology Blastoma Cancer Treatment Chronic Lymphocytic Leukemia Glioblastoma Hematopoietic Stem Cell Immune System Immunology Immunotherapies Immunotherapy Leukemia

    Related ETFs - A few ETFs which own one or more of the above listed Hematologic Malignancies stocks.

    Symbol Grade Name Weight
    IDNA C iShares Genomics Immunology and Healthcare ETF 3.88
    FBT D First Trust Amex Biotech Index Fund 3.29
    CNCR D Loncar Cancer Immunotherapy ETF 2.88
    WDNA D WisdomTree BioRevolution Fund 2.58
    XBI D SPDR S&P Biotech ETF 2.46
    View all Hematologic Malignancies ETFs...
    Compare ETFs
    Compare CNCR to WDNA Compare IDNA to FBT Compare WDNA to XBI

        Hematologic Malignancies Stocks Recent News

        Date Stock Title
        May 17 INCY Here's Why Incyte (INCY) Stock is Up More Than 7% in a Week
        May 16 CRBU Expert Ratings For Caribou Biosciences
        May 16 FATE Alibaba To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Thursday
        May 15 APTO Aptose Biosciences Inc. (APTO) Q1 2024 Earnings Call Transcript
        May 14 INCY Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress
        May 14 SLS SELLAS Life Sciences GAAP EPS of -$0.21
        May 14 APTO Aptose Biosciences GAAP EPS of -$0.73 beats by $0.09
        May 14 APTO Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses
        May 14 SLS SELLAS Life Sciences Reports First Quarter 2024 Financial Results and Provides Corporate Update
        May 14 APTO Aptose Reports Results for the First Quarter 2024
        May 14 AFMD Affimed Announces Acceptance of an Abstract on Preclinical Data of its Innate Cell Engager AFM28 at the European Hematology Association 2024 Congress
        May 14 KYMR Kymera Therapeutics to Present New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting
        May 14 INCY Company News For May 14, 2024
        May 14 AFMD Immatics (IMTX) Reports Q1 Loss, Tops Revenue Estimates
        May 14 INCY Heard on the Street Monday Recap: Hello Kitty
        May 13 INCY Health Care Roundup: Market Talk
        May 13 INCY Tech Stocks Inch Higher Ahead Of Key Inflation Data, GameStop Skyrockets, Tencent Fuels China Rally: What's Driving Markets Monday?
        May 13 INCY Incyte Stock Marks Biggest Jump in 7 Years on ‘Dutch Auction’ Buyback Plan. How It Works.
        May 13 FATE Fate Therapeutics, Inc. (NASDAQ:FATE) Q1 2024 Earnings Call Transcript
        May 13 INCY Incyte Launches $1.67 Billion Share Repurchase 'Dutch Auction' Tender Offer; to Buy Back $328 Million of Baker Entities' Shares
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Solid Tumors Cancer Medicine Biotechnology Clinical Medicine Acute Myeloid Leukemia CD19 Tumors Of The Hematopoietic And Lymphoid Tissues Biology Blastoma Cancer Treatment Chronic Lymphocytic Leukemia Glioblastoma Hematopoietic Stem Cell Immune System Immunology Immunotherapies Immunotherapy Leukemia
        Hematologic Malignancies

        Hematologic malignancies are cancers of the blood, bone marrow, and lymphatic system. These cancers can affect the production and function of blood cells, leading to a variety of symptoms and complications. Common types of hematologic malignancies include leukemia, lymphoma, and multiple myeloma. Treatment for hematologic malignancies may include chemotherapy, radiation therapy, stem cell transplant, and targeted therapy.

        Browse All Tags